Prescription Drugs

Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.

Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.

GGMP Deviations: Possible contamination with impurity N-nitrosodimethylamine (NDMA).

GGMP Deviations: Possible contamination with impurity N-nitrosodimethylamine (NDMA).

Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.

Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.

Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.

Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.

CGMP Deviations: Presence of NDMA impurity detected in product.

Presence of Foreign Substance: Black particles were found in the lots during retain sample inspection

Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.

Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.

Failed Impurities/Degradation Specifications: Tretinoin levels slightly above specification limits.

CGMP Deviations: Presence of NDMA impurity detected in product.

GGMP Deviations: Possible contamination with impurity N-nitrosodimethylamine (NDMA).

Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.

Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.

Lack of Assurance of Sterility

Marketed without an Approved NDA/ANDA: FDA analysis found this product to contain undeclared Tadalafil, an FDA approved drug for the treatment of erectile dysfunction.

Lack of Assurance of Sterility